GeneDx Holdings Corp. Overview
Pro stress-test →GeneDx Holdings is a genomics company providing pediatric and rare disease diagnostics through whole exome and genome sequencing. The company translates complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies.
Strategic Profile
Pro stress-test →GeneDx is positioned as a leader in advanced exome and genome diagnostics, leveraging its expanding rare disease dataset. The company develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.
Competitive Landscape
Pro stress-test →GeneDx operates in the $20B+ precision medicine market as a genomics leader. Primary competitors include other clinical genomics labs focused on rare disease diagnostics, variant interpretation, and data analytics. GeneDx differentiates through its large proprietary dataset and AI-driven platform.
Industry Context
GeneDx Holdings Corp. operates in Genomic Diagnostics & Precision Medicine.
Key facts
Founded: 2015 · Headquarters: Stamford, CT · Employees: 1,000 · Revenue: $305.45M (2024)